Effect of recombinant human endostatin onradiotherapy for esophagus cancer

Gao-Feng LIU; Hui CHANG; Bao-Tian LI; Yong ZHANG; Dan-Dan LI; Yan LIU; Yang YANG

Gao-Feng LIU; Hui CHANG; Bao-Tian LI; Yong ZHANG; Dan-Dan LI; Yan LIU; Yang YANG.

Asian Pacific Journal of Tropical Medicine ; (12): 86-90, 2016.

Article in Zh | WPRIM | ID: wpr-951485

Responsible library: WPRO

ABSTRACT

ABSTRACT

Objective: To investigate the effect of radiotherapy plus recombinant human endostatin (RH-endostatin) on esophageal cancer and its mechanism. Methods: A total of 50 nudemice were equally randomized into control group, radiotherapy group, and combined therapy group I, II, and III after inoculating with Eca109 cell suspension (1 × 10

Key words

Esophageal cancer; Nudemice; Radiotherapy; Recombinant human endostatin; Vascular endothelial growth factor

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: WPRIM Language: Zh Journal: Asian Pacific Journal of Tropical Medicine Year: 2016 Type: Article

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: WPRIM Language: Zh Journal: Asian Pacific Journal of Tropical Medicine Year: 2016 Type: Article